BRAF/MEK inhibitor-induced tumor lysis syndrome in a patient with malignant melanoma

被引：0
|
作者：
Maeda, Shintaro [1 ]
Imazaki, Katsuya [1 ]
Shimizu, Kyoko [1 ]
Oishi, Kyosuke [1 ]
Hamaguchi, Yasuhito [1 ]
Matsushita, Takashi [1 ]
机构：
[1] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Med, Dept Mol Pathol Skin, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan
来源：
JOURNAL OF DERMATOLOGY | 2025年 / 52卷 / 03期
关键词：
D O I：
10.1111/1346-8138.17507
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：e242 / e243
页数：2
相关论文
共 50 条
  • [1] A case of BRAF inhibitor-induced pancreatitis in a patient with malignant melanoma
    Sugiyama, Tomoko
    Fukuchi, Kensuke
    Kitauchi, Yurie
    Shimauchi, Takatoshi
    Ishida, Natsuki
    Honda, Tetsuya
    EUROPEAN JOURNAL OF DERMATOLOGY, 2025, 34 (05) : 563 - 564
  • [2] Tumor lysis syndrome induced by BRAF/MEK double blockade in a patient with metastatic melanoma: A first case report
    Tachibana, Kota
    Ohe, Shuichi
    Tanaka, Mari
    Maniwa, Tomohiro
    Isei, Taiki
    JOURNAL OF DERMATOLOGY, 2021, 48 (07): : E324 - E326
  • [3] Brugada syndrome induced by BRAF and MEK inhibitors in a melanoma patient
    Nardin, Charlee
    Colas, Morgane
    Badoz, Marc
    Roche-Kubler, Blandine
    Meneveau, Nicolas
    Puzenat, Eve
    Aubin, Francois
    EUROPEAN HEART JOURNAL, 2017, 38 (27) : 2151 - 2151
  • [4] Tumor lysis syndrome and malignant melanoma
    Mouallem, Meir
    Zemer-Wassercug, Noa
    Kugler, Eitan
    Sahar, Nadav
    Shapira-Frommer, Ronnie
    Schiby, Ginette
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [5] Tumor lysis syndrome and malignant melanoma
    Meir Mouallem
    Noa Zemer-Wassercug
    Eitan Kugler
    Nadav Sahar
    Ronnie Shapira-Frommer
    Ginette Schiby
    Medical Oncology, 2013, 30
  • [6] Tumor Lysis Syndrome being treated by highly selective BRAF-Inhibitor in a Patient with metastisized malign Melanoma
    Groffik, A.
    Rudolph, B.
    Weirich, O.
    Mitzel-Kaoukhov, H.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (09): : 785 - 785
  • [7] BRAF Inhibitor-Induced Antitumoral Granulomatous Dermatitis Eruption in Advanced Melanoma
    Garrido, Maria C.
    Gutierrez, Carlota
    Riveiro-Falkenbach, Erica
    Ortiz, Pablo
    Rodriguez-Peralto, Jose L.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2015, 37 (10) : 795 - 798
  • [8] The role of basal and BRAF inhibitor-induced autophagy-driven secretion in remodeling the melanoma tumor secretome
    Kraya, Adam
    Speicher, David W.
    Amaravadi, Ravi
    CANCER RESEARCH, 2015, 75
  • [9] MEK inhibitor-induced chronic paronychia
    Zhou, Cici
    Davis, DiAnne
    Haskell, Henry
    Levin, Jarad
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB92 - AB92
  • [10] Treatment of BRAF inhibitor-induced hyperkeratosis
    Battley, Jodie E.
    Lenihan, Elizabeth
    Redmond, Henry P.
    Murphy, Michelle
    Power, Derek G.
    ACTA ONCOLOGICA, 2013, 52 (04) : 874 - U235
12345